Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 7 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 3 days agoParticipants were administered either a 10μg dose of mRNA-1283 or a 50μg dose of Spikevax. In March...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 7 days ago"It really reduces the burden on health care systems and pharmacies," Mock told IBD. "Now they can...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Combined mRNA COVID-flu vaccine shows promise in Moderna trial
Semafor via Yahoo News· 6 days agoSome 22.9% of adults in the US got a coronavirus vaccine this winter, while 48.5% got the flu shot,...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 3 days agoCyanVac and its affiliate Blue Lake Biotechnology are developing the single-dose, intranasal vaccine...
High-risk health workers can get routine Ebola vaccine, Gavi says
Reuters· 4 days agoA global stockpile of Ebola vaccines can be used to protect frontline health workers in high-risk...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 5 days agoModerna reported that a single dose of mRNA-1083 met immunogenicity non-inferiority criteria versus...